Technical Development of a New Meningococcal Conjugate Vaccine

Background. Group A Neisseria meningitidis has been a major cause of bacterial meningitis in the sub-Saharan region of Africa in the meningitis belt. Neisseria meningitidis is an encapsulated pathogen, and antibodies against the capsular polysaccharide are protective. Polysaccharide–protein conjugat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Infect Dis
Autori principali: Frasch, Carl E., Kapre, Subhash V., Lee, Che-Hung, Préaud, Jean-Marie
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2015
Soggetti:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639497/
https://ncbi.nlm.nih.gov/pubmed/26553667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ595
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi